VAYBIC

Serial Number 97150742
Registration 7854440
700

Registration Progress

Application Filed
Dec 1, 2021
Under Examination
Approved for Publication
May 20, 2025
Published for Opposition
May 20, 2025
Registered
Jul 8, 2025

Trademark Image

VAYBIC

Basic Information

Serial Number
97150742
Registration Number
7854440
Filing Date
December 1, 2021
Registration Date
July 8, 2025
Published for Opposition
May 20, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 8, 2025
Registration
Registered
Classes
005

Rights Holder

Sun Pharma Advanced Research Company Limited

16
Address
17/B, Mahal Industrial Estate
Mahakali Caves Road, Andheri (East)
Mumbai 400093
IN

Ownership History

Sun Pharma Advanced Research Company Limited

Original Applicant
16
Mumbai IN

Sun Pharma Advanced Research Company Limited

Owner at Publication
16
Mumbai IN

Sun Pharma Advanced Research Company Limited

Original Registrant
16
Mumbai IN

Legal Representation

Attorney
Craig Kuchii

USPTO Deadlines

Next Deadline
2171 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-07-08)
Due Date
July 08, 2031
Grace Period Ends
January 08, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description Documents
Jul 8, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 8, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 20, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 20, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 14, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 19, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 15, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 15, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Apr 15, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 17, 2025 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Jan 17, 2025 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jan 17, 2025 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Jul 11, 2024 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Jul 11, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jul 11, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jun 28, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 28, 2024 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jun 28, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 2, 2024 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Apr 2, 2024 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Apr 2, 2024 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Oct 4, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Oct 4, 2023 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Oct 4, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Sep 27, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 27, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 27, 2023 ALIE A ASSIGNED TO LIE Loading...
May 8, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Feb 10, 2023 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Feb 10, 2023 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Feb 10, 2023 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Aug 13, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 13, 2022 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Aug 13, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 9, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 6, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 4, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations and substances for the treatment of ophthalmic diseases and disorders

Classification

International Classes
005